Hannonen PJ - Search Results

1

Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs.

Kauppi MJ, Neva MH, Laiho K, Kautiainen H, Luukkainen R, Karjalainen A, Hannonen PJ, Leirisalo-Repo M, Korpela M, Ilva K, Möttönen T; FIN-RACo Trial Group. Kauppi MJ, et al. Among authors: hannonen pj. J Rheumatol. 2009 Feb;36(2):273-8. doi: 10.3899/jrheum.080429. J Rheumatol. 2009. PMID: 19132793 Clinical Trial.

2

Erosions develop rarely in joints without clinically detectable inflammation in patients with early rheumatoid arthritis.

Sokka T, Kautiainen H, Möttönen T, Hannonen P. Sokka T, et al. J Rheumatol. 2003 Dec;30(12):2580-4. J Rheumatol. 2003. PMID: 14719197

3

Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.

Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M. Puolakka K, et al. Arthritis Rheum. 2004 Jan;50(1):55-62. doi: 10.1002/art.11436. Arthritis Rheum. 2004. PMID: 14730599 Free article. Clinical Trial.

4

Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years.

Sokka T, Kautiainen H, Häkkinen A, Hannonen P. Sokka T, et al. J Rheumatol. 2004 Jun;31(6):1073-82. J Rheumatol. 2004. PMID: 15170917

5

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.

Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Blåfield H, Puolakka K, Möttönen T; FIN-RACo Trial Group. Korpela M, et al. Arthritis Rheum. 2004 Jul;50(7):2072-81. doi: 10.1002/art.20351. Arthritis Rheum. 2004. PMID: 15248204 Free article. Clinical Trial.

6

Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. a 5-year followup study.

Mäkinen H, Kautiainen H, Hannonen P, Sokka T. Mäkinen H, et al. J Rheumatol. 2005 May;32(5):796-800. J Rheumatol. 2005. PMID: 15868611

7

Survey nonresponse is associated with increased mortality in patients with rheumatoid arthritis and in a community population.

Kauppi M, Sokka T, Hannonen P. Kauppi M, et al. J Rheumatol. 2005 May;32(5):807-10. J Rheumatol. 2005. PMID: 15868613

8

Conventional disease-modifying antirheumatic drugs in early arthritis.

Sokka T, Hannonen P, Möttönen T. Sokka T, et al. Rheum Dis Clin North Am. 2005 Nov;31(4):729-44. doi: 10.1016/j.rdc.2005.07.007. Rheum Dis Clin North Am. 2005. PMID: 16287594 Review.

9

Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.

Mäkinen H, Kautiainen H, Hannonen P, Möttönen T, Leirisalo-Repo M, Laasonen L, Korpela M, Blåfield H, Hakola M, Sokka T. Mäkinen H, et al. J Rheumatol. 2007 Feb;34(2):316-21. Epub 2006 Dec 15. J Rheumatol. 2007. PMID: 17183623 Clinical Trial.

10

Prognosis of 5-year radiographic erosions of the wrist according to early, late, and persistent wrist swelling or tenderness in patients with early rheumatoid arthritis.

Luukkainen R, Sokka T, Kautiainen H, Hannonen P, Laasonen L, Leirisalo-Repo M, Korpela M, Julkunen H, Puolakka K, Blåfield H, Kauppi M, Möttönen T; FIN-RACo Trial Group. Luukkainen R, et al. J Rheumatol. 2007 Jan;34(1):50-3. J Rheumatol. 2007. PMID: 17216677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page